KALA
Price
$7.11
Change
-$0.70 (-8.96%)
Updated
Feb 23, 6:59 PM EST
PALI
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Feb 23, 6:59 PM EST
Ad is loading...

Analysis and predictions KALA vs PALI

Header iconKALA vs PALI Comparison
Open Charts KALA vs PALIBanner chart's image
Kala BIO
Price$7.11
Change-$0.70 (-8.96%)
Volume$28.47K
CapitalizationN/A
Palisade Bio
Price$0.40
Change-$0.02 (-4.76%)
Volume$137.62K
CapitalizationN/A
View a ticker or compare two or three
KALA vs PALI Comparison Chart

Loading...

KALADaily Signal changed days agoGain/Loss if shorted
 
Show more...
PALIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
KALA vs. PALI commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a StrongSell and PALI is a Hold.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (KALA: $7.06 vs. PALI: $0.40)
Brand notoriety: KALA and PALI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 119% vs. PALI: 7%
Market capitalization -- KALA: $19.01M vs. PALI: $4.9M
KALA [@Biotechnology] is valued at $19.01M. PALI’s [@Biotechnology] market capitalization is $4.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green whilePALI’s FA Score has 2 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • PALI’s FA Score: 2 green, 3 red.
According to our system of comparison, PALI is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 4 TA indicator(s) are bullish while PALI’s TA Score has 2 bullish TA indicator(s).

  • KALA’s TA Score: 4 bullish, 6 bearish.
  • PALI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, KALA is a better buy in the short-term than PALI.

Price Growth

KALA (@Biotechnology) experienced а -0.42% price change this week, while PALI (@Biotechnology) price change was -6.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

KALA is expected to report earnings on May 09, 2023.

PALI is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for KALA with price predictions.
OPEN
A.I.dvisor published
a Summary for PALI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KALA($19M) has a higher market cap than PALI($4.9M). KALA has higher P/E ratio than PALI: KALA (11.06) vs PALI (1.26). KALA YTD gains are higher at: 0.857 vs. PALI (-31.525). PALI has higher annual earnings (EBITDA): -13.03M vs. KALA (-40.18M). KALA has more cash in the bank: 56.1M vs. PALI (15.3M). PALI has less debt than KALA: PALI (498K) vs KALA (36.1M). PALI has higher revenues than KALA: PALI (250K) vs KALA (0).
KALAPALIKALA / PALI
Capitalization19M4.9M388%
EBITDA-40.18M-13.03M308%
Gain YTD0.857-31.525-3%
P/E Ratio11.061.26876%
Revenue0250K-
Total Cash56.1M15.3M367%
Total Debt36.1M498K7,249%
FUNDAMENTALS RATINGS
KALA vs PALI: Fundamental Ratings
KALA
PALI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6393
P/E GROWTH RATING
1..100
942
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PALI's Valuation (20) in the null industry is somewhat better than the same rating for KALA (53) in the Pharmaceuticals Major industry. This means that PALI’s stock grew somewhat faster than KALA’s over the last 12 months.

PALI's Profit vs Risk Rating (100) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.

PALI's SMR Rating (98) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that PALI’s stock grew similarly to KALA’s over the last 12 months.

KALA's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as PALI (93) in the null industry. This means that KALA’s stock grew similarly to PALI’s over the last 12 months.

PALI's P/E Growth Rating (2) in the null industry is significantly better than the same rating for KALA (94) in the Pharmaceuticals Major industry. This means that PALI’s stock grew significantly faster than KALA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KALAPALI
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
KALADaily Signal changed days agoGain/Loss if shorted
 
Show more...
PALIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTZ7.430.17
+2.34%
Hertz Global Holdings
AXR21.450.11
+0.52%
AMREP Corp
IMCC0.33N/A
-0.08%
IM Cannabis Corp
SBS16.01-0.23
-1.42%
Companhia DE Saneamento B Sico DO Estado DE SAO Paulo-Sabesp Ads's
ISPR10.00-0.20
-1.96%
Ispire Technology

KALA and

Correlation & Price change

A.I.dvisor tells us that KALA and ATHE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KALA and ATHE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-11.75%
ATHE - KALA
32%
Poorly correlated
-16.18%
PALI - KALA
31%
Poorly correlated
-4.38%
HOTH - KALA
30%
Poorly correlated
N/A
ARDX - KALA
30%
Poorly correlated
-1.59%
FWBI - KALA
27%
Poorly correlated
+14.90%
More

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been loosely correlated with ARAV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PALI jumps, then ARAV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-4.38%
ARAV - PALI
45%
Loosely correlated
N/A
SEER - PALI
35%
Loosely correlated
-1.91%
NBSE - PALI
35%
Loosely correlated
-5.33%
ARTL - PALI
32%
Poorly correlated
-7.74%
NBY - PALI
27%
Poorly correlated
+0.65%
More